Stock Comparison
ABBV vs BIIB
AbbVie Inc and Biogen Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$447.62B
$31.89B
P/E (TTM)
123.6
23.3
Forward P/E
17.8
14.5
Price/Sales
7.1
3.2
Price/Book
50.5
1.6
EV/EBITDA
30.2
11.9
Dividend Yield
2.77%
—
Profitability
Net Margin
5.79%
13.80%
Operating Margin
32.20%
22.90%
Return on Equity
62.30%
7.70%
Return on Assets
10.00%
5.95%
Growth (YoY)
Revenue Growth
12.40%
1.90%
Earnings Growth
-46.20%
31.10%
Price & Risk
Beta
0.3
0.2
52-Week High
$253.35
$218.06
52-Week Low
$176.02
$121.05
Analyst Target
$254.38
$220.25
Compare ABBV and BIIB your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.